Speaker illustration

Doctor Anna Klimenko

RUDN University, Moscow (Russian Federation)

Prognostic value of bioimpedance vector analysis-assessed cachexia in patients with decompensated heart failure

Event: Heart Failure 2019

Topic: Epidemiology, Prognosis, Outcome

Session: Acute Heart Failure – Epidemiology, Prognosis, Outcome

Thumbnail

Urine biomarkers as determinants of poor outcomes in patients with acute kidney injury and heart failure with mid-range ejection fraction

Event: Heart Failure 2018

Topic: Heart Failure with Mid-Range Ejection Fraction (HFmrEF)

Session: Chronic Heart Failure – Pathophysiology and Mechanisms

Thumbnail

The value of bioimpedance vector analysis in decompensated heart failure patients with mid-range ejection fraction

Event: Heart Failure 2018

Topic: Heart Failure with Mid-Range Ejection Fraction (HFmrEF)

Session: Chronic Heart Failure – Pathophysiology and Mechanisms

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb